Christine Zahren

Co-Founder & Director

White Coats Foundation, Australia

Christine has 25+ years of diverse healthcare experience spanning aged care, acute care, rehabilitation medicine, dermatology specialist clinics, and surgery. Her extensive background includes significant expertise as a clinical trial nurse coordinator and she spent 5 years in a leadership role managing the Dermatology clinical trial unit at the Skin Health Institute in Victoria. During this time, she successfully oversaw multiple clinical trials, contributing to breakthrough treatments in dermatological conditions such as psoriasis, eczema and various skin cancers.

Christine holds a Bachelor of Nursing and a Master of Applied Science in Chinese Medicine (Acupuncture). This unique combination of qualifications gives her a holistic perspective on healthcare delivery and treatment options.
Currently, she serves as the Business Development Manager for ClinTrial Refer—an innovative mobile app and website platform that connects clinicians and patients with current clinical trials.
She is also the Co-founder and Director of the White Coats Foundation, a not-for-profit charity dedicated to raising awareness about the vital role of clinical trials in advancing medical science and healthcare. The Foundation has launched multiple initiatives aligned with its charitable purpose, with campaigns collectively reaching thousands of people. White Coats Foundation has also partnered with major teaching hospitals in Australia to deliver events aimed at raising awareness about clinical trials and the importance of the patient role.

Christine’s passion lies in advocating for patient access to developmental medications and cutting edge therapies, ensuring innovative treatments reach those who need them. She firmly believes in empowering patients through knowledge and works to dismantle barriers to clinical trial participation. She adopts a collaborative approach to healthcare innovation and is a dedicated champion for healthcare advancement and equitable access to medical innovation.